Across TCGA pan-cancer cohorts, DEFB107A Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated DEFB107A data layer compared with 2 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher DEFB107A Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated DEFB107A expression acts as an unfavorable survival marker.

COAD are the cancer types where DEFB107A Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.183	0.806	.004	27	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: DEFB107A tumor-vs-normal RNA expression · all DEFB107A data types